RNAscope for VEGF-A Detection in Human Tumor Bioptic Specimens

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Vascular Endothelial Growth Factor-A (VEGF-A) and its receptor VEGFR2 drive tumor angiogenesis, impacting prognosis.
• Anti-angiogenic therapies targeting VEGF-A show limited clinical benefit due to drug resistance.
• Robust biomarkers are needed for patient stratification in anti-VEGF therapy.

Purpose of the Study:

• To present a detailed protocol for VEGF-A mRNA detection and quantification in human tumor samples.
• To establish a reliable method for identifying potential responders to anti-VEGF therapies.
• To support personalized therapeutic approaches in oncology.

Main Methods:

• Utilized RNAscope technology for chromogenic detection of VEGF-A mRNA.
• Applied RNA in situ hybridization (ISH) algorithm for quantification.
• Validated the protocol on human tumor bioptic specimens.

Main Results:

• Demonstrated successful detection and quantification of VEGF-A mRNA, even in small amounts.
• RNAscope method is compatible with precious clinical samples.
• The protocol integrates with diagnostic laboratory workflows.

Conclusions:

• RNAscope provides a robust method for VEGF-A mRNA detection and quantification in tumors.
• This technique can serve as a biomarker for patient stratification in anti-VEGF therapy.
• The protocol supports personalized medicine by identifying therapy responders.